Kakehi, Y <br/><br/>
Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas.  [electronic resource] 

 -  Japanese journal of cancer research : Gann  Feb 1998 
 - 214-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0910-5050 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.1998.tb00551.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genes, p53<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Kidney Pelvis<br/>Male<br/>Middle Aged<br/>Nuclear Proteins<br/>Prognosis<br/>Proto-Oncogene Proteins--biosynthesis<br/>Proto-Oncogene Proteins c-mdm2<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--biosynthesis<br/>Ureteral Neoplasms--drug therapy<br/>Urinary Bladder Neoplasms--drug therapy<br/>Urologic Neoplasms--drug therapy